[1] 钱晓军, 戴定可, 翟仁友, Qian xiaojun, DAI Dingke, ZHAI Renyou. 恶性梗阻性黄疸介入治疗的疗效分析 [J]. 中华肝胆外科杂志 2004.doi:10.3760/cma.j.issn.1007-8118.2004.11.011
[2] 罗祖炎, 陈方宏, 袁建华, 俞文强, 刘子江. 胆道双金属支架植入姑息性治疗肝门胆管癌的临床价值 [J]. 介入放射学杂志 2004.doi:10.3969/j.issn.1008-794X.2004.05.025
[3] 翟仁友, 戴定可, 王剑锋, 于平, 魏宝杰, ZHAI Ren-you, DAI Ding-ke, WANG Jian-feng, YU Ping, WEI Bao-jie. 高位胆管梗阻的介入治疗和近期疗效分析 [J]. 介入放射学杂志 2006.doi:10.3969/j.issn.1008-794X.2006.08.014
[4] 陈耀庭, 许林锋, 马海清, 骆江红, 江容坚, 周经兴, 何艳芬. 肝门部胆管癌内支架置入术后再梗阻的介入处理 [J]. 肿瘤防治研究 2004.doi:10.3971/j.issn.1000-8578.2004.10.015
[5] 谢宗贵, 张希全, 李凡东, 金鹏, 易玉海, 张绪平. 胆道支架技术5年回顾(213例随访报告) [J]. 中华肝胆外科杂志 2002.doi:10.3760/cma.j.issn.1007-8118.2002.10.006
[6] 郑建伟, 唐涛, 肖宝来, 陈波, 李宏, 程海斌, 邹声泉. 内磁场在磁靶向治疗胆道恶性肿瘤中作用的实验研究 [J]. 北京医学 2006.doi:10.3969/j.issn.0253-9713.2006.12.008
[7] 郭元星, 李彦豪, 陈勇, 俞志坚, 陈平雁, 罗鹏飞, 李勇, 单鸿, 姜在波. 金属支架、内涵管治疗恶性胆道梗阻的临床疗效比较(多中心研究) [J]. 第一军医大学学报 2003.doi:10.3321/j.issn:1673-4254.2003.12.018
[8] 韩新巍, 李永东, 马南, 邢古生, 马波, 吴刚. 胆管癌性阻塞内支架术后再狭窄的介入治疗 [J]. 介入放射学杂志 2002.doi:10.3969/j.issn.1008-794X.2002.05.013
[9] 范卫君, 吴沛宏, 张亮, 黄金华, 张福君, 顾仰葵, 赵明, 黄祥龙, 郭昌宇, FAN Wei-jun, WU Pei-hong, ZHANG Liang, HUANG Jin-hua, ZHANG Fu-jun, GU Yang-kui, ZHAO Ming, HUANG Xiang-long, GUO Chang-yu. Ⅲ、Ⅳ型肝门区胆管腺癌的介入治疗 [J]. 中华放射学杂志 2005.doi:10.3760/j.issn:1005-1201.2005.09.007
[10] 何贵金, 张申众, 金永柏, 曹明洲, 姜维国, 戴显伟, 高红, 蒋涛, 马凯. 103钯放射性支架持续照射犬胆管放射性损伤的研究 [J]. 中华实验外科杂志 2004.doi:10.3760/j.issn:1001-9030.2004.02.052
[11] 李玉, 王宁, 田起和, 郭占文, 张海波, 宋丽艳. 金属支架联合立体定向适形放疗治疗肝门部胆管癌 [J]. 中华放射肿瘤学杂志 2005.doi:10.3760/j.issn:1004-4221.2005.01.009
[12] KLATSHIN G. Adenocarcinoma of the hepatic duct at the bifurcation within the porta hepatitis:an unususal tumor with distinctive clinical and pathological features [J]. American Journal of Medicine 1965, 38.
[13] 石景森, 王炳煌. 外科黄疸疾病诊断治疗学 [M]. 北京:人民军医出版社 2003.
[14] POLIKARPOV A A, KOZLOV A V, TARAZOV P G. Role of interventional radiography in the treatment of the hepato-pancreato-duodenal area, complicated by obstructive jaundice [J]. Voprosy Onkologii 2002, 48(02).
[15] Miura Y, Endo I, Togo S, Sekido H, Misuta K, Fujii Y, Kubota T, Tanaka K, Nagahori K, Shimada H. Adjuvant therapies using biliary stenting for malignant biliary obstruction. [J]. Journal of hepato-biliary-pancreatic surgery 2001, 2(2).
[16] CARRASCO C H, ZORNOZA J, BECHTEL W J. Malignant biliary obstruction complications of percutaneous biliary drainage [J]. Radiology 1984, 152(02).
[17] Inal M, Akgul E, Aksungur E, Seydaoglu G. Percutaneous placement of biliary metallic stents in patients with malignant hilar obstruction: unilobar versus bilobar drainage. [J]. Journal of vascular and interventional radiology: JVIR 2003, 11(11).
[18] Chang, WH, Kortan, P, Haber, GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. [J]. Gastrointestinal Endoscopy 1998, 5(5).
[19] Tsuyuguchi T, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Kondo S, Furuse J, Saito H, Suyama M, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Amano H, Miura F. Stenting and interventional radiology for obstructive jaundice in patients with unresectable biliary tract carcinomas. [J]. Journal of hepato-biliary-pancreatic surgery 2008, 1(1).
[20] ROEREN T, TONN W, RICHTER G M. Percutaneous therapy of malignant obstructive jaundice using expandable metal stents:a prospective study of 92 patients [J]. ROFO:Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 1996, 165(02).
[21] HAUSEGGER K A, MISCHINGER H J, KARAIC R. Percutaneous holangioscopy in obstruction biliary metal stents [J]. Cardiovascular and Interventional Radiology 1997, 20(03).
[22] Nishiyama Y, Yamamoto Y, Kimura N, Miki A, Sasakawa Y, Wakabayashi H, Ohkawa M. Comparison of early and delayed FDG PET for evaluation of biliary stricture. [J]. Nuclear Medicine Communications 2007, 12(12).
[23] SOULEZ G, GAGNER M, THERASSE E. Malignant biliary obstruction:Premilinary results of palliative treatment with hepaticogastrostomy under fluoroscopic, endoscopic and laparoscopic guidance [J]. Radiology 1994, 192(01).
[24] 李麟荪, 贺能树. 介入放射学--非血管性 [M]. 北京:人民卫生出版社 2001.
[25] HARDER J, BLUM H E. Cholangiocarcinoma [J]. SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS 2002, 91(34).
[26] Taieb J, Mitry E, Boige V, Artru P, Ezenfis J, Lecomte T, Clavero Fabri MC, Vaillant JN, Rougier P, Ducreux M. [J]. Annals of oncology: official journal of the European Society for Medical Oncology 2002.
[27] Kim TW, Chang HM, Kang HJ, Lee JR, Ryu MH, Ahn JH, Kim JH, Lee JS, Kang YK. [J]. Annals of oncology: official journal of the European Society for Medical Oncology 2003.
[28] KUHN R, HRIBASCHEK A, EICHELMANN K. Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangiocarcinomas [J]. Investigational New Drugs 2002, 20(03).
[29] POON R T, NG K K, LAM C M. Learning curve for radiofrequency ablation of liver tumors:prospective analysis of initial 100 patients in a tertiary institution [J]. Annals of Surgery 2004, 239(04).
[30] Valek V, Kysela P, Kala Z, Kiss I, Tomasek J, Petera J. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: A prospective randomised study. [J]. European Journal of Radiology 2007, 2(2).
[31] MEZAWA S, HOMMA H, SATO T. A study of carboplatin-coated tube for the unresectable cholangiocarcioma [J]. Hepatology 2000, 32(05). |
